Met Life Investment Management, LLC Edgewise Therapeutics, Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 42,271 shares of EWTX stock, worth $1.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
42,271
Previous 42,271
-0.0%
Holding current value
$1.3 Million
Previous $761,000
48.23%
% of portfolio
0.01%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding EWTX
# of Institutions
191Shares Held
100MCall Options Held
2.17MPut Options Held
410K-
Orbimed Advisors LLC San Diego, CA15MShares$462 Million9.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$274 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$185 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$180 Million1.67% of portfolio
-
Novo Holdings Hellerup, G75.55MShares$171 Million10.36% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.94B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...